Skip to main content
Clinical Trials/NL-OMON23785
NL-OMON23785
Recruiting
Not Applicable

Treating the compromised hearts of patients with Rheumatoid Arthritis ¨C Can we repair the damage?

Reade0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Reade
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Reade

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of:
  • o RA, according to the ARC/EULAR 2010 criteria (11\)
  • \- Active disease (DAS28\=3\.2\) AND C\-reactive protein \>10 mg/l OR erythrocyte sedimentation rate (ESR) \>15mm/h)
  • \- Minimal knee bending/flexion angle of 90 degrees of both knees.
  • \- Age 40\-70 years

Exclusion Criteria

  • \- Medical history of myocardial infarction or congestive heart failure NYHA class III/IV.

Outcomes

Primary Outcomes

Not specified

Similar Trials